{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T02:00:41Z","timestamp":1792720841565,"version":"4.5.0"},"reference-count":32,"publisher":"Consortium of Multiple Sclerosis Centers","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2015,1,1]]},"abstract":"<jats:p>Background: Multiple sclerosis (MS) can adversely affect gait, causing gait slowing, loss of balance, decreased functional mobility, and gait deficits, such as footdrop. Current treatments for gait dysfunction due to MS are pharmacologic, using dalfampridine, or orthotic, using an ankle-foot orthosis. Functional electrical stimulation (FES) to the fibular nerve stimulates active dorsiflexion and provides an alternative treatment for gait dysfunction caused by footdrop. The objective of this study was to determine the effect of FES on gait function and the impact of MS on walking and quality of life for people with MS taking a stable dalfampridine dose.<\/jats:p>\n               <jats:p>Methods: Participants demonstrating gait slowing and footdrop completed the Timed 25-Foot Walk (T25FW) test, 6-Minute Walk (6MW) test, GaitRite Functional Ambulation Profile, 12-item Multiple Sclerosis Walking Scale (MSWS-12), and 36-item Short Form Health Status Survey (SF-36) at screening without FES; the measures were repeated with FES at baseline, 1 month, and 3 months.<\/jats:p>\n               <jats:p>Results: Twenty participants (8 men and 12 women) completed this unblinded case series study. The mean age, duration of MS, and time taking dalfampridine were 51.7, 15.8, and 1.4 years, respectively. Changes from screening to baseline and screening to 3 months were analyzed. Significant improvement was noted from screening to baseline for the MSWS-12 (P = .024) and SF-36 Physical Function domain (P = .028) and from screening to 3 months for the T25FW (P = .015), MSWS-12 (P = .003), and SF-36 Physical Function (P = .032) and Role Limitation\u2013Physical Health (P = .012) domains.<\/jats:p>\n               <jats:p>Conclusions: Improvements above those induced pharmacologically suggest that FES can augment pharmacologic intervention and significantly improve gait function, decrease the impact of MS on walking, and improve quality of life for people with MS.<\/jats:p>","DOI":"10.7224\/1537-2073.2013-033","type":"journal-article","created":{"date-parts":[[2014,7,14]],"date-time":"2014-07-14T16:36:26Z","timestamp":1405355786000},"page":"35-41","source":"Crossref","is-referenced-by-count":26,"title":["Effects of Functional Electrical Stimulation on Gait Function and Quality of Life for People with Multiple Sclerosis Taking Dalfampridine"],"prefix":"10.7224","volume":"17","author":[{"given":"Lori","family":"Mayer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tina","family":"Warring","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie","family":"Agrella","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helen L.","family":"Rogers","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward J.","family":"Fox","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"4242","reference":[{"key":"2020060300561087200_i1537-2073-17-1-35-b1","article-title":"Atlas: country resources for neurological disorders 2004: results of a collaborative study of the World Health Organization and the World Federation of Neurology","author":"World Health Organization"},{"key":"2020060300561087200_i1537-2073-17-1-35-b2","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1191\/026921598675863454","article-title":"A comparison of two physiotherapy treatment approaches to improve walking in multiple sclerosis: a pilot randomized controlled study","volume":"12","author":"Lord","year":"1998","journal-title":"Clin Rehabil"},{"key":"2020060300561087200_i1537-2073-17-1-35-b3","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1177\/135245859900500511","article-title":"A profile of multiple sclerosis: the New York State Multiple Sclerosis Consortium","volume":"5","author":"Jacobs","year":"1999","journal-title":"Mult Scler"},{"key":"2020060300561087200_i1537-2073-17-1-35-b4","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1185\/03007990903433528","article-title":"Contribution of impaired mobility to patient burden in multiple sclerosis","volume":"26","author":"Sutliff","year":"2010","journal-title":"Curr Med Res Opin"},{"key":"2020060300561087200_i1537-2073-17-1-35-b5","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1177\/1352458508101320","article-title":"A randomized trial to investigate the effects of functional electrical stimulation and therapeutic exercise on walking performance for people with multiple sclerosis","volume":"15","author":"Barrett","year":"2009","journal-title":"Mult Scler"},{"key":"2020060300561087200_i1537-2073-17-1-35-b6","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1097\/PHM.0b013e31815e6680","article-title":"Effects of a new radio frequency-controlled neuroprosthesis on gait symmetry and rhythmicity in patients with chronic hemiparesis","volume":"87","author":"Hausdorff","year":"2008","journal-title":"Am J Phys Med Rehabil"},{"key":"2020060300561087200_i1537-2073-17-1-35-b7","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1177\/1545968309347681","article-title":"Long-term therapeutic and orthotic effects of a foot drop stimulator on walking performance in progressive and nonprogressive neurological disorders","volume":"24","author":"Stein","year":"2010","journal-title":"Neurorehabil Neural Repair"},{"key":"2020060300561087200_i1537-2073-17-1-35-b8","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1177\/1756285611403960","article-title":"Treatment of walking impairment in multiple sclerosis with dalfampridine","volume":"4","author":"Blight","year":"2011","journal-title":"Ther Adv Neurol Disord"},{"key":"2020060300561087200_i1537-2073-17-1-35-b9","article-title":"AMPYRA medication guidelines and prescribing information","author":"Acorda Therapeutics"},{"key":"2020060300561087200_i1537-2073-17-1-35-b10","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1212\/01.wnl.0000326213.89576.0e","article-title":"Dose comparison trial of sustained-release fampridine in multiple sclerosis","volume":"71","author":"Goodman","year":"2008","journal-title":"Neurology"},{"key":"2020060300561087200_i1537-2073-17-1-35-b11","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1177\/1352458508090667","article-title":"The effect of functional electrical stimulation on the physiological cost of gait in people with multiple sclerosis","volume":"14","author":"Paul","year":"2008","journal-title":"Mult Scler"},{"key":"2020060300561087200_i1537-2073-17-1-35-b12","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.jstrokecerebrovasdis.2008.08.006","article-title":"Neuroprosthesis for footdrop compared with ankle-foot orthosis: effects on postural control during walking","volume":"18","author":"Ring","year":"2009","journal-title":"J Stroke Cerebrovasc Dis"},{"key":"2020060300561087200_i1537-2073-17-1-35-b13","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1177\/1545968306289292","article-title":"A multicenter trial of a footdrop stimulator controlled by a tilt sensor","volume":"20","author":"Stein","year":"2006","journal-title":"Neurorehabil Neural Repair"},{"key":"2020060300561087200_i1537-2073-17-1-35-b14","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1177\/1545968309349939","article-title":"Does functional electrical stimulation for foot drop strengthen corticospinal connections?","volume":"24","author":"Everaert","year":"2010","journal-title":"Neurorehabil Neural Repair."},{"key":"2020060300561087200_i1537-2073-17-1-35-b15","doi-asserted-by":"crossref","first-page":"437","DOI":"10.2522\/ptj.20070035","article-title":"Therapeutic effects of an implantable peroneal nerve stimulator in subjects with chronic stroke and footdrop: a randomized clinical trial","volume":"88","author":"Kottink","year":"2008","journal-title":"Phys Ther"},{"key":"2020060300561087200_i1537-2073-17-1-35-b16","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1016\/S0003-9993(99)90333-7","article-title":"Clinical use of the Odstock dropped foot stimulator: its effect on the speed and effort of walking","volume":"80","author":"Taylor","year":"1999","journal-title":"Arch Phys Med Rehabil"},{"key":"2020060300561087200_i1537-2073-17-1-35-b17","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1161\/01.STR.26.6.982","article-title":"Classification of walking handicap in the stroke population","volume":"26","author":"Perry","year":"1995","journal-title":"Stroke"},{"key":"2020060300561087200_i1537-2073-17-1-35-b18","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1177\/1352458512444498","article-title":"Assessing walking disability in multiple sclerosis","volume":"18","author":"Kieseier","year":"2012","journal-title":"Mult Scler"},{"key":"2020060300561087200_i1537-2073-17-1-35-b19","doi-asserted-by":"crossref","first-page":"59","DOI":"10.2147\/PROM.S32241","article-title":"Assessment set for evaluation of clinical outcomes in multiple sclerosis: psychometric properties","volume":"3","author":"Rasova","year":"2012","journal-title":"Patient Relat Outcome Meas"},{"key":"2020060300561087200_i1537-2073-17-1-35-b20","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1177\/1352458507082607","article-title":"Evaluation of the six-minute walk in multiple sclerosis subjects and healthy controls","volume":"14","author":"Goldman","year":"2008","journal-title":"Mult Scler"},{"key":"2020060300561087200_i1537-2073-17-1-35-b21","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.gaitpost.2008.07.011","article-title":"Gait analysis in multiple sclerosis: characterization of temporal\u2013spatial parameters using GAITRite functional ambulation system","volume":"29","author":"Givon","year":"2009","journal-title":"Gait Posture"},{"key":"2020060300561087200_i1537-2073-17-1-35-b22","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1212\/WNL.60.1.31","article-title":"Measuring the impact of MS on walking ability: the 12-Item MS Walking Scale (MSWS-12)","volume":"60","author":"Hobart","year":"2003","journal-title":"Neurology"},{"key":"2020060300561087200_i1537-2073-17-1-35-b23","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/j.gaitpost.2010.02.011","article-title":"Multiple Sclerosis Walking Scale-12 and oxygen cost of walking","volume":"31","author":"Motl","year":"2010","journal-title":"Gait Posture"},{"key":"2020060300561087200_i1537-2073-17-1-35-b24","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1136\/jnnp.2003.029660","article-title":"Quality of life and impairment in patients with multiple sclerosis","volume":"76","author":"Isaksson","year":"2005","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"2020060300561087200_i1537-2073-17-1-35-b25","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1177\/135245850000600411","article-title":"The significant change for the Timed 25-Foot Walk in the Multiple Sclerosis Functional Composite","volume":"6","author":"Kaufman","year":"2000","journal-title":"Mult Scler"},{"key":"2020060300561087200_i1537-2073-17-1-35-b26","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1185\/03007995.2011.639752","article-title":"Minimally important clinical difference of the Timed 25-Foot Walk Test: results from a randomized controlled trial in patients with multiple sclerosis","volume":"28","author":"Coleman","year":"2012","journal-title":"Curr Med Res Opin"},{"key":"2020060300561087200_i1537-2073-17-1-35-b27","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1177\/1352458506070658","article-title":"Gait and balance impairment in early multiple sclerosis in the absence of clinical disability","volume":"12","author":"Martin","year":"2006","journal-title":"Mult Scler"},{"key":"2020060300561087200_i1537-2073-17-1-35-b28","first-page":"645197","article-title":"Gait variability and multiple sclerosis","volume":"2013","author":"Socie","year":"2013","journal-title":"Mult Scler Int"},{"key":"2020060300561087200_i1537-2073-17-1-35-b29","first-page":"846","article-title":"Increased energy cost of walking in multiple sclerosis: effect of spasticity, ataxia and weakness","volume":"69","author":"Olgiati","year":"1988","journal-title":"Arch Phys Med Rehabil"},{"key":"2020060300561087200_i1537-2073-17-1-35-b30","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1136\/jnnp.69.3.353","article-title":"Relation between abnormal patterns of muscle activation and response to common peroneal nerve stimulation in hemiplegia","volume":"69","author":"Burridge","year":"2000","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"2020060300561087200_i1537-2073-17-1-35-b31","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.3109\/09638281003599596","article-title":"Restoration of gait and motor recovery by functional electrical stimulation therapy in persons with stroke","volume":"32","author":"Sabut","year":"2010","journal-title":"Disabil Rehabil"},{"key":"2020060300561087200_i1537-2073-17-1-35-b32","doi-asserted-by":"crossref","first-page":"393","DOI":"10.3233\/NRE-2011-0717","article-title":"Functional electrical stimulation of dorsiflexor muscle: effects on dorsiflexor strength, plantarflexor spasticity, and motor recovery in stroke patients","volume":"29","author":"Sabut","year":"2011","journal-title":"NeuroRehabilitation"}],"container-title":["International Journal of MS Care"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/meridian.allenpress.com\/ijmsc\/article-pdf\/17\/1\/35\/2091709\/1537-2073_2013-033.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/meridian.allenpress.com\/ijmsc\/article-pdf\/17\/1\/35\/2091709\/1537-2073_2013-033.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,17]],"date-time":"2025-07-17T21:11:46Z","timestamp":1752786706000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ijmsc.org\/view\/effects-of-functional-electrical-stimulation-on-gait-function-and-quality-of-life-for-people-with-multiple-sclerosis-taking-dalfampridine"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,1,1]]},"references-count":32,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,1,1]]}},"URL":"https:\/\/doi.org\/10.7224\/1537-2073.2013-033","relation":{},"ISSN":["1537-2073"],"issn-type":[{"value":"1537-2073","type":"print"}],"subject":[],"published":{"date-parts":[[2015,1,1]]}}}